This study investigates neuroendocrine tumors. The purpose of this study is to compare the effectiveness of an investigational medication with everolimus in participants who have advanced forms of these tumors.
The study evaluates the safety and effectiveness of the investigational medication in treating neuroendocrine tumors. It focuses on understanding how well the investigational medication works compared to everolimus.
- Who can participate: Participants must be adults with advanced neuroendocrine tumors that are well-differentiated. They should have measurable disease and documented progression. Prior treatments are allowed based on specific criteria.
- Study details: Participants will receive either the investigational treatment or everolimus. A placebo may be used in the study.
How understandable was the trial content above?
Hard to understand
Easy to understand